2Doggrell SA. Recent important clinical trials of drugs in osteoporosis [ J ]. Expert Opin Pharmacother ,2004,5 ( 7 ) : 1635
3Robert PH. Advances in therapy for osteoporosis [J]. Clin Med Res , 2003,1 : 93
4Nakayama H. Active vitamin D3 therapy for gulucocorticoid-induced osteoporosis [J]. Clin Calcium ,2006,16 ( 7 ) : 117
5Delmas PD, Ensrud KE, Adachi JD, et al. Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial [ J ]. J Clin Endocrinol Metab ,2002,87 ( 8 ) : 3609
6Cauley JA,Norton L,Lippman ME, et al. Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4- year results from the MORE trial. Multiple outcomes of raloxifene evaluation [ J ]. Breast Cancer Res Treat, 2001,65 (2) : 125
7Secrist J. Osteoporosis Part IV-rapid review of drug therapies (A to Z ) for preventing male osteoporosis/fractures [ J ]. Urul Nuts, 2003,23(2) :168
8Sunyecz JA, Weisman SM. The role of calcium in osteoporosis drug therapy[ J]. J Womens Health ( Larchmt ) ,2005,14(2) : 180
9Miura T. Suzuki H. Instruction on the use of drugs to an osteoporosis curative medicine [ J ]. Nippon Rinsho ,2003,61 (2) :274
10Riggs BL, Parfitt AM. Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling[J]. J Bone Miner Res ,2005,20(2) : 177
